EANM Guidelines Referral Guidelines Workshop F. Verzijlbergen September 21, 2012 Vienna.

Slides:



Advertisements
Similar presentations
1 Terms of Reference for the GEO Executive Committee Note: These Terms of References were approved at GEO-6 Helen Wood, GEO Secretariat Director.
Advertisements

CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
Carcinoma scarsamente differenziato Terapia radiorecettoriale
PET Radiopharmaceuticals by Stephen M. Karesh, Ph.D.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection For Subcutaneous, Intraperitoneal, Intravenous and Oral Use For Diagnostic Use by.
Nuclear Medicine Spring 2009 FINAL. 2 NM Team Nuclear medicine MD Nuclear medicine MD Physicist Physicist Pharmacist Pharmacist Technologist Technologist.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
To reduce the burden of cardiovascular disease in Europe.
Radioisotopes in Medicine
Philippines A Country Report on Nuclear Medicine Developments
DIAGNOSTIC $ THERAPEUTIC NUCLEAR MEDICINE. Presented at the KNH Research Symposium On 13 th April 2012 PRESENTER: DR. DAVID NDIRANGU THEURI Nuclear medicine.
© Nuclear MedicineVersion 26.Jan.2010 European Perspective: Multicenter Clinical Trials Production Valerie Treyer, PhD 1,2 Gustav K. von Schulthess, MD,
AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.
Radionuclide methods in oncology Otto Lang, MD, PhD Otakar Bělohlávek, MD, CSc Dept Nucl Med Charles Univ, 3rd Med Fac Materials for medical students.
PET/CT & PET/MRI Radiopharmacy
Introduction to Nuclear Medicine
International Atomic Energy Agency L 4 PROTECTION ISSUES IN CLINICAL METHODOLOGY.
PET-CT in Scotland Dr Fergus McKiddie John Mallard PET Centre Aberdeen Royal Infirmary.
RADIOPHARMACY Diagnostic Nuclear Medicine 4 continue 7.
radio-iodinated metaiodobenzylguanidine (123I-MIBG)
Radiophamaceuticals in Nuclear Cardiac Imaging Vasken Dilsizian, M.D. Professor of Medicine and Radiology Director of Cardiovascular Nuclear Medicine and.
CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.
SNM Update Michael M. Graham, PhD, MD. SNM/ACNP GR Plan 2 SNM ACNP GR Plan Enhanced the Government Relations Existing Plan for Developed a Government.
Career in Biomedical Technology Objective 2 Imaging Careers & Technology.
Organization and guideline development April 2010 ACCC The Netherlands.
Summary of Current and Planned Reports and Conferences of the National Council on Radiation Protection and Measurements Thomas S. Tenforde President Interagency.
DOE SUPPORT OF NUCLEAR MEDICINE RESEARCH Alan B. Packard, Ph.D. Vice President Radiopharmaceutical Sciences Council Society of Nuclear Medicine.
Future goals of EFOMP in education, profession and science.
Multipartite “College Nuclear Medicine” (Founded in October 2004) A) General aim: “Role of Nuclear Medicine (Molecular) Imaging in Evidence Based Medicine”
Pediatric Nuclear Medicine and the RDRC Regulations Michael J. Gelfand M.D. Cincinnati Children’s Hospital Cincinnati, OH Past-President, Society of Nuclear.
WELCOME. PET/CT CASE REVIEW COURSE JANUARY 31 ST PASADENA CONVENTION CENTER LOS ANGELES RADIOLOGIC SOCIETY MID WINTER MEETING.
Health Budgets & Financial Policy CPT/HCPCS 2010 Updates 12 January 2010 – 0800 & 1400 & 2100 EST 14 January 2010 – 0800 & 1400 Bridge Number:
Ultrasound, Positron Emission Tomography, and Single Photon Emission Tomography Allen T. Newton, Ph.D. PAVE 2014.
Future goals of EFOMP in education, profession and science.
By Rini Agustin.  Introduction  Radioctive and How radioactive is produced : atom, radioactivity and radioactive decay  Radiopharmaceutical preparation.
Molecular Imaging & Positron Emission Tomography Nicholas Mulhern BME 281.
Zevalin™ Kit manufactured by IDEC Pharmaceuticals BLA September 11, 2001 FDA Presentation to the Oncologic Drugs Advisory Committee.
BERAC April 2004 Radiopharmaceutical Sub- committee Report.
Introduction to NM Omima Adam NMT 231. What is nuclear medicine NM Is the branch of medicine that uses radiation and nuclear properties of radionuclide's.
Head of NMD of FSCH, Clinical Prof. B.Enkhtuya, RCA/UNDP Project Promoting and Accelerating Nuclear SPECT/PET Imaging Technologies in the.
CERTIFICATION OF MEDICAL PHYSICIST – INDIAN PERSPECTIVE DR. ARUN CHOUGULE ; Ph.D. ASSOCAITE PROF. RADIATION PHYSICS & RSO INCHARGE TELEMEDICINE S.M.S.
COUNTRY REPORT: PHILIPPINES Dr. Miriam Joy C. Calaguas.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
Malaysia National Workplan on IAEA/RCA “Strengthening Clinical Applications of PET in RCA Member States (RAS/6/049) Presented by: Dr. Mohamed Ali Abdul.
Indonesia Final Report RCA-UNDP Nepal, November 2013.
An overview of the role of Nuclear Medicine in Pulmonary diseases
EURAMED The Medical platform for Radiation Protection Research
Supporting “PEACEFUL SAFE AND SECUR APLICATION”
Multipartite “College Nuclear Medicine” (Founded in October 2004)
Image Reading Course in Nuclear Medicine
Pulmonary artery stent infection
Melanoma Staging an update
Heather Patterson - Australia -
Career in Biomedical Technology Objective 2
Summers B, Ekosse T Background Research Topics Objectives
Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer Eur Thyroid J 2016;5:
Coordination (benign lesions)
Career in Biomedical Technology Objective 2
Overview of Nuclear Technologies in Healthcare
IAEA CN-255 Paper233 PEDIATRIC RADIATION PROTECTION THROUGH 99mTc -DMSA ADMINISTRED ACTIVITY STUDY AT NUCLEAR MEDICINE DEPARTMENT, CONSTANTINE, ALGERIA.
TOPIC: NUCLEAR MEDICINE PRACTICE IN KENYA
Chapter 19: Radionuclide Therapy
Radioisotopes in Medicine
Nuclear Medicine Residency New Program Requirements
Current Status of Nuclear Medicine in the Philippines
Breast Sentinel Node Scintigraphy
Gender representation of board members in all international societies (reference year: 2016). Gender representation of board members in all international.
Clinical case report platform
Presentation transcript:

EANM Guidelines Referral Guidelines Workshop F. Verzijlbergen September 21, 2012 Vienna

EANM: facts & figures individual members 39 national societies 16 affiliated members (countries outside Council of Europe)

EANM – Governance and Bodies Executive Committee Members Assembly Advisory Council Delegates Assembly 12 Committees 1 Task Group European School of Nuclear Medicine Executive Secretariat in Vienna with In-House Congress Management Educational Facility at the Executive Secretariat in Vienna

EANM Committees Cardiovascular Committee Dosimetry Committee Drug Development Committee Inflammation & Infection Neuroimaging Committee Oncology Committee Paediatrics Committee Physics Committee Radionuclide Therapy Committee Radiopharmacy Committee Technologist Committee Translational Molecular Imaging Committee Bone and Joint Committee

EANM Guidelines Dosimetry C 1. EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Radioiodine Test Prior to Radioiodine Therapy of Benign Thyroid Disease (revision 2012 in progress) 2. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting (publication: 2010) 3.EANM Dosimetry Committee guidelines for bone marrow and whole- body dosimetry (publication: 2010) 3. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry: blood and bone marrow dosimetry in differentiated thyroid cancer therapy (publication: 2008) 4.

EANM Guidelines Paediatrics C 1. Guidelines for standard and diuretic renogram in children (publication: 2011) 2. Guideline for radioiodinated MIBG scintigraphy in children (publication: 2011) 3. Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride (publication: 2010) 4. Guidelines on 99mTc-DMSA Scintigraphy in children (publication: 1 st version 2001, revised version 2009) 5. Guidelines for lung scintigraphy in children (publication: 2007) 6. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology (date of publication: not-available)

EANM Guidelines GL stimulated by the scientific committees, chaired by someone from the C, Members for GL preparation are easily attracted because publication in the EJNMMI is almost guaranteed (IF 6) with a lot of citations (Citation Index), In the last few years clinical members in the committee preparing the GL, Presented during the Annual Congress by the NM- physician and clinical specialist and vice-versa (succesfull with new techniques/approaches),

EANM relations : ECCO, ESTRO, EORTC, ASCO, EACR ALLIANCE FOR BIOMEDICAL RESEARCH UEMS/EBNM ESTRO, MIRO EFOMP ESMI, ESOI ECR ESR, ESMOFIR IAEA SNM EAU EFNS OECD, AIPES

EANM Guidelines Cardiovascular C 1.Hybrid cardiac imaging: SPECT/CT and PET/CT (A joint position statement by the European Association of Nuclear Medicine (EANM), the Eur. Society of Cardiac Radiology /ESCR/ and the European Council of Nuclear Cardiology /ECNC/) (publication: 2010) 2.EANM/ESC guidelines for radionuclide imaging of cardiac function (publication: 2008) 3. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology (publication: 2005, under revision)

EANM Guidelines Oncology C 7. PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? (publication by EANM & ESTRO 2010) 8. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma (publication: 2009) 9. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma (publication: 2009) 10. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 (publication: 2009) 11. Sentinel node in breast cancer procedural guidelines (publication: 2007)

EANM Guidelines Parallel GL prepared by technologists (mainly cardiovascular) Further improvement by cross checking with the SNM (started 2011), SNM/EANM Guideline for Guideline Development 6.0* (publication: 2012) SNMMI Guidelines (EANM endorsement) 1. SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0* (publication: 2010; EANM revision & endorsement 2012) 2. SNM Practice Guideline for Breast Scintigraphy with Breast-Specific g-Cameras 1.0* (publication: 2010; EANM revision & endorsement 2012) EANM Guidelines (SNMMI endorsement) I/123I-Metaiodobenzylguanidine (mIBG) Scintigraphy – Procedures Guidelines for Tumour Imaging (publication: 2010; SNMMI revision & endorsement 2012) 2. EANM procedure guideline of radio-immunotherapy for B-cell lymphoma with 90Y radiolabeled ibritumomab tiuxetan - Zevalin® (publication: 2006; SNMMI revision & endorsement 2012) Finally: imaging standardization, FDG-PET accreditation over Europe

Do the GL work? Most European NM physicians check the request the day before the actual study (recipe), Pharmacists and Physicists are members of the team, Working according to GL is a constant issue during audits, Further improvement on the clinicians side.